Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Sun Yat-sen University Cancer Center · Guangzhou

Dr. Hong Shaodong洪少东

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Hong Shaodong

Professional overview

Hong Shaodong is an Associate Chief Physician in the Department of Medical Oncology at Sun Yat-sen University Cancer Center, specializing in systemic therapy for thoracic malignancies and nasopharyngeal carcinoma.

SpecialtyMedical oncology
Clinical titleAssociate Chief Physician
Academic rolesMaster's Supervisor
DepartmentDepartment of Medical Oncology
HospitalSun Yat-sen University Cancer Center
CityGuangzhou

Areas of focus

Lung cancerFocuses on chemotherapy, targeted therapy, immunotherapy, and palliative care for lung cancer, with particular experience in managing resistance to targeted therapy and comprehensive immunotherapy management.
Nasopharyngeal carcinomaProvides chemotherapy, targeted therapy, immunotherapy, and palliative care for nasopharyngeal carcinoma.
Clinical trialsOffers opportunities for participation in novel drug clinical trials.

Experience & recognition

  • Recipient of the China Anti-Cancer Association (CACA) Science and Technology Award (First Prize)
  • Recipient of the Guangdong Medical Science and Technology Award (First Prize, inaugural)
  • Recipient of the American Society of Clinical Oncology (ASCO) Cancer Foundation Award
  • Recipient of the International Association for the Study of Lung Cancer (IASLC) International Mentorship Program Award
  • Named among CSCO's '35 Most Promising Young Oncologists in China'
  • Recognized as an Outstanding Model in Lung Cancer under the 'People's Good Doctor – Golden Camellia Program' (Second Edition)
  • Published over 30 SCI papers in journals including The Lancet, The Lancet Oncology, Journal of Clinical Oncology (JCO), JAMA Oncology, Nature Communications, Journal of Thoracic Oncology, and Journal for ImmunoTherapy of Cancer
  • Research incorporated into the U.S. National Comprehensive Cancer Network (NCCN) guidelines at the highest evidence level
  • Principal investigator of three grants from the National Natural Science Foundation of China (NSFC)

Professional roles

  • Youth Committee Member, Thoracic Oncology Specialty Committee, World Chinese Association of Oncologists
  • Member, Youth Committee, Chinese Society of Clinical Oncology (CSCO)
  • Member, Youth Committee on Lung Cancer, Chinese Society of Clinical Oncology (CSCO)
  • Vice Chair, Tumor Emergency and Critical Care Specialty Committee, Guangdong Thoracic Disease Society
  • Vice Chair, Tumor Microenvironment Specialty Committee, Guangzhou Anti-Cancer Association

Frequently asked questions

What does Dr. Hong Shaodong specialize in?

Specializes in chemotherapy, targeted therapy, immunotherapy, and palliative care for lung cancer, nasopharyngeal carcinoma, malignant pleural mesothelioma, and thymic carcinoma; also experienced in managing targeted therapy resistance, global immunotherapy management, and novel drug clinical trials.

Which hospital and department is Dr. Hong Shaodong in?

Department of Medical Oncology at Sun Yat-sen University Cancer Center

Sources

Dr. Hong Shaodong has not reviewed this page.